CLINICAL_TRIALS
trial_result
· 2025-12-10
Clinical Trial Update: FFNP-PET/MR Imaging of Progesterone Receptor Expression in Invasive Breast Cancer [Phase 2]
Summary
A Phase 2 trial evaluating FFNP-PET/MR imaging of progesterone receptor expression in invasive breast cancer has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Wisconsin, Madison | Conditions: Invasive Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2025-12-10